Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer
This clinical trial update outlines a study that uses patient-derived organoids to functionally characterize chemotherapy resistance in brea…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer [Phase 1]
Phase 1 neoadjuvant trial evaluating DPX-Survivac with an aromatase inhibitor, radiotherapy, or cyclophosphamide in hormone receptor-positiv…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer [Phase 1, Phase 2]
Hoffmann-La Roche is conducting a Phase 1/2 study to evaluate the safety and efficacy of multiple treatment combinations in patients with es…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective Surveillance for Breast Cancer-Related Lymphedema [NA]
Clinical trial update for a prospective surveillance of breast cancer-related lymphedema. Sponsored by Rigshospitalet in Denmark, the study …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Exercise Training in Women With Metastatic Breast Cancer [NA]
Clinical trial update about exercise training for women with metastatic breast cancer; the study is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients [Phase 2]
Phase 2 trial of nivolumab, ipilimumab, and bicalutamide for HER2-negative breast cancer is active and not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
This clinical trial update evaluates the diagnostic performance of 18F-FDG PET/CT to detect distant metastases in locally advanced or metast…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients [NA]
A clinical trial is recruiting to evaluate telenursing for early detection and management of side effects in breast cancer patients treated …
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) [Phase 3]
Phase 3 randomized trial RAPID2 evaluating five-fraction partial breast irradiation is currently recruiting; sponsor is Ontario Clinical Onc…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics [Phase 1]
This report covers the completion of a Phase I study evaluating tolerance and pharmacokinetics of the investigational agent TQB3616 in patie…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer [Phase 1]
This update reports completion of a Phase Ib dose-escalation study evaluating taselisib (GDC-0032) in combination with anti-HER2 therapies i…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.
This pooled analysis from the HeCOG study reports outcomes for patients with early-stage breast cancer treated with adjuvant dose-dense sequ…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates [Phase 2]
A multicenter, single-arm Phase II exploratory trial evaluating eribulin plus anlotinib for HER2-negative recurrent/metastatic breast cancer…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. [Phase 2]
A Phase 2 trial at UC San Diego is exploring AI/ML-guided rechallenge with CDK4/6 inhibitors for breast cancer, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer [Phase 3]
Phase 3 trial evaluating palbociclib for HR-positive, HER2-negative isolated locoregional recurrence of breast cancer. The study is currentl…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. [Phase 4]
An ongoing Phase 4 trial is examining whether body mass index influences the plasma exposure of the trastuzumab deruxtecan payload (Free-DXd…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy
A retrospective evaluation of ultrasound-assisted tumor surgery in breast-conserving therapy for breast cancer has completed (NCT07519668).
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer [NA]
A clinical trial is evaluating the efficacy of a novel probiotic on the bacteriome and mycobiome in breast cancer patients. The study is cur…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive [Phase 2, Phase 3]
Clinical trial update comparing RO7771950 versus tucatinib, each in combination with trastuzumab and capecitabine, for HER2-positive breast …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer [Phase 1, Phase 2]
Clinical trial update for TALAVE evaluating induction talazoparib followed by combination of talazoparib and avelumab in advanced breast can…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: CBD for Breast Cancer Primary Tumors [Phase 1]
A Phase 1 clinical trial is evaluating cannabidiol (CBD) for primary tumors in breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer [Phase 2]
This Phase 2 clinical trial is evaluating whether Avelumab or Hydroxychloroquine, with or without Palbociclib, can eliminate dormant breast …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
This study evaluated real-world effectiveness of palbociclib plus endocrine therapy as first- or second-line treatment for HR+/HER2- advance…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Ongoing MD Anderson trial investigating temporal immunologic changes following hypofractionated radiation-induced DNA damage in breast cance…